P Schiantarelli

460 total citations
34 papers, 381 citations indexed

About

P Schiantarelli is a scholar working on Molecular Biology, Physiology and Organic Chemistry. According to data from OpenAlex, P Schiantarelli has authored 34 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Physiology and 7 papers in Organic Chemistry. Recurrent topics in P Schiantarelli's work include Asthma and respiratory diseases (5 papers), Pharmacological Receptor Mechanisms and Effects (4 papers) and Drug-Induced Hepatotoxicity and Protection (4 papers). P Schiantarelli is often cited by papers focused on Asthma and respiratory diseases (5 papers), Pharmacological Receptor Mechanisms and Effects (4 papers) and Drug-Induced Hepatotoxicity and Protection (4 papers). P Schiantarelli collaborates with scholars based in Italy, France and Germany. P Schiantarelli's co-authors include S Bongrani, Daniela Acerbi, Roberta Razzetti, C.A. Rizzi, H. Ladinsky, Marco Turconi, Lorenzo Pavesi, A. Donetti, Franco Borsini and Aline Dumuis and has published in prestigious journals such as British Journal of Pharmacology, Atherosclerosis and Journal of Molecular and Cellular Cardiology.

In The Last Decade

P Schiantarelli

31 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P Schiantarelli Italy 11 131 101 67 64 57 34 381
X. Y. Wei United States 7 152 1.2× 76 0.8× 58 0.9× 12 0.2× 46 0.8× 8 351
Robert H. Hook United States 12 224 1.7× 47 0.5× 30 0.4× 37 0.6× 76 1.3× 20 442
Minxue Huang Belgium 9 174 1.3× 63 0.6× 187 2.8× 68 1.1× 33 0.6× 16 685
Annalisa Aggio Italy 9 75 0.6× 38 0.4× 65 1.0× 35 0.5× 62 1.1× 16 453
W. D. Erdmann Germany 12 65 0.5× 43 0.4× 23 0.3× 157 2.5× 43 0.8× 58 473
Shigeru Ueki Japan 8 78 0.6× 58 0.6× 69 1.0× 143 2.2× 239 4.2× 17 420
Anu Singh United States 7 81 0.6× 104 1.0× 32 0.5× 135 2.1× 27 0.5× 7 364
Paul W. Frankel United States 6 110 0.8× 26 0.3× 53 0.8× 92 1.4× 201 3.5× 6 489
M Amico-Roxas Italy 12 136 1.0× 66 0.7× 57 0.9× 46 0.7× 44 0.8× 52 484
J D Harry United Kingdom 11 85 0.6× 65 0.6× 65 1.0× 36 0.6× 49 0.9× 26 461

Countries citing papers authored by P Schiantarelli

Since Specialization
Citations

This map shows the geographic impact of P Schiantarelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Schiantarelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Schiantarelli more than expected).

Fields of papers citing papers by P Schiantarelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Schiantarelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Schiantarelli. The network helps show where P Schiantarelli may publish in the future.

Co-authorship network of co-authors of P Schiantarelli

This figure shows the co-authorship network connecting the top 25 collaborators of P Schiantarelli. A scholar is included among the top collaborators of P Schiantarelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Schiantarelli. P Schiantarelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rizzi, C.A., A. Sagrada, Achille Schiavone, et al.. (1994). Gastroprokinetic properties of the benzimidazolone derivative BIMU 1, an agonist at 5-hydroxytryptamine4 and antagonist at 5-hydroxytryptamine3 receptors. Naunyn-Schmiedeberg s Archives of Pharmacology. 349(4). 338–345. 20 indexed citations
2.
Schiantarelli, P. (1993). Therapeutic Potential of Cholecystokinin Receptor Antagonists in CNS Disorders. Pharmacological Research. 28(1). 1–9. 8 indexed citations
3.
Dumuis, Aline, H. Gozlan, Michèle Sebben, et al.. (1992). Characterization of a novel 5-HT4 receptor antagonist of the azabicycloalkyl benzimidazolone class: DAU 6285. Naunyn-Schmiedeberg s Archives of Pharmacology. 345(3). 264–9. 46 indexed citations
4.
Sagrada, A., Marco Turconi, P Schiantarelli, et al.. (1991). Antiemetic activity of the new 5-HT3 antagonist DAU 6215 in animal models of cancer chemotherapy and radiation. Cancer Chemotherapy and Pharmacology. 28(6). 470–474. 9 indexed citations
5.
Berti, F., Fulvio Magni, Giuseppe Rossoni, S Bongrani, & P Schiantarelli. (1990). Pharmacological activity of bamifylline on lung anaphylaxis: studies. Pharmacological Research. 22(2). 143–150. 2 indexed citations
6.
ROMA, G., et al.. (1989). [Chemistry and pharmacology of pyrane derivatives. XVII. Synthesis of substituted 2-(dialkylamino)-3-formylchromones and their tricyclic derivatives].. PubMed. 44(6). 565–77. 6 indexed citations
7.
Berti, F., et al.. (1988). New pharmacological data on the bronchospasmolytic activity of bamifylline.. PubMed. 38(1). 40–4. 4 indexed citations
8.
Mazzei, Mauro, et al.. (1986). [Chemistry and pharmacology of pyran derivatives. XVII. Synthesis of 2-(dialkylamino)-5-hydroxychromones and their transformation to derivatives of 2H-pyran[4,3,2-de]-1-benzopyran].. PubMed. 41(8). 611–21.
9.
Bongrani, S, Roberta Razzetti, & P Schiantarelli. (1985). Cardiovascular Effects of Nicardipine in Anesthetized Open-Chest Dogs in the Absence and Presence of β-Adrenergic Receptor Blockade: A Comparison with Nifedipine and Verapamil. Journal of Cardiovascular Pharmacology. 7(5). 899–905. 23 indexed citations
10.
Razzetti, Roberta, S Bongrani, & P Schiantarelli. (1984). In vitro effects of nicarpidine on vascular and cardiac muscle preparations. Pharmacological Research Communications. 16(8). 795–808. 11 indexed citations
11.
Schiantarelli, P, et al.. (1984). A gastroprotective anti-inflammatory agent: theβ-morpholinoethyl ester of niflumic acid (morniflumate). Inflammation Research. 14(2). 247–256. 6 indexed citations
12.
Bongrani, S, et al.. (1983). Potentiation of leukotriene C4 bronchoconstriction by beta-adrenoceptor antagonists in the guinea pig.. PubMed. 12. 173–8. 5 indexed citations
13.
Bongrani, S, Giancarlo Folco, Roberta Razzetti, & P Schiantarelli. (1983). β2‐Adrenoceptor blockade is the basis of guinea‐pig bronchial hyper‐responsiveness to leukotriene C4and other agonists. British Journal of Pharmacology. 79(4). 839–848. 13 indexed citations
14.
Schiantarelli, P & S Bongrani. (1981). Quantification of the synergism between fenoterol and ipratropium bromide in the counteraction of experimental bronchospasm. Inflammation Research. 11(6-7). 693–698.
15.
Schiantarelli, P, et al.. (1981). Piroxicam pharmacologic activity and gastrointestinal damage by oral and rectal route. Comparison with oral indometacin and phenylbutazone.. PubMed. 31(1). 87–92. 18 indexed citations
16.
Schiantarelli, P & W Murmann. (1980). Antispasmodic activity of rociverine on the smooth musculature of the urinary tract. Comparative in vitro study.. PubMed. 30(7). 1102–9. 2 indexed citations
17.
Schiantarelli, P, W Murmann, & Simona Magi. (1979). Investigation of rociverine + dipyrone for antispasmodic and analgesic interactions.. PubMed. 29(5). 760–5. 5 indexed citations
18.
Schiantarelli, P, et al.. (1978). Rociverine, a new antispasmodic agent with balanced neurotropic and myotropic activity.. PubMed. 28(7). 1130–42. 3 indexed citations
19.
Schiantarelli, P, et al.. (1978). Polyvalent antiinflammatory activity of a polyanionic fraction of bovine pancreas. Potential value in the treatment of atherosclerosis.. PubMed. 28(7). 1146–53. 2 indexed citations
20.
Tirone, Piero, P Schiantarelli, & G. Rosati. (1973). Pharmacological activity of some neuro-transmitters in the isolated thoracic duct of dogs.. PubMed. 6(2). 65–8. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026